316 related articles for article (PubMed ID: 33509278)
1. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
Karnik NS; Campbell CI; Curtis ME; Fiellin DA; Ghitza U; Hefner K; Hser YI; McHugh RK; Murphy SM; McPherson SM; Moran L; Mooney LJ; Wu LT; Shmueli-Blumberg D; Shulman M; Schwartz RP; Stephens KA; Watkins KE; Marsden J
Trials; 2021 Jan; 22(1):102. PubMed ID: 33509278
[TBL] [Abstract][Full Text] [Related]
2. The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study.
Karnik NS; Marsden J; McCluskey C; Boley RA; Bradley KA; Campbell CI; Curtis ME; Fiellin D; Ghitza U; Hefner K; Hser YI; McHugh RK; McPherson SM; Mooney LJ; Moran LM; Murphy SM; Schwartz RP; Shmueli-Blumberg D; Shulman M; Stephens KA; Watkins KE; Weiss RD; Wu LT
Addiction; 2022 Sep; 117(9):2438-2447. PubMed ID: 35293064
[TBL] [Abstract][Full Text] [Related]
3. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
Trials; 2014 Jun; 15():247. PubMed ID: 24962012
[TBL] [Abstract][Full Text] [Related]
4. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
[TBL] [Abstract][Full Text] [Related]
5. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
[TBL] [Abstract][Full Text] [Related]
6. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.
Byrne M; O'Connell A; Egan AM; Dinneen SF; Hynes L; O'Hara MC; Holt RIG; Willaing I; Vallis M; Hendrieckx C; Coyne I
Trials; 2017 Dec; 18(1):602. PubMed ID: 29258565
[TBL] [Abstract][Full Text] [Related]
7. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
[TBL] [Abstract][Full Text] [Related]
8. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
[TBL] [Abstract][Full Text] [Related]
9. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
[TBL] [Abstract][Full Text] [Related]
10. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
11. Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol.
Qiu R; Li M; Zhang X; Chen S; Li C; Shang H
Trials; 2018 Oct; 19(1):541. PubMed ID: 30290840
[TBL] [Abstract][Full Text] [Related]
12. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
[TBL] [Abstract][Full Text] [Related]
13. Development of a Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): a study protocol.
D'Souza R; Hall C; Sermer M; Siu S; Silversides C
Trials; 2020 Mar; 21(1):300. PubMed ID: 32228655
[TBL] [Abstract][Full Text] [Related]
14. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
[TBL] [Abstract][Full Text] [Related]
15. Developing a core outcome set for the treatment of pregnant women with pregestational diabetes-a study protocol.
Kgosidialwa O; Bogdanet D; Egan A; O'Shea PM; Biesty L; Devane D; Dunne F;
Trials; 2020 Dec; 21(1):1017. PubMed ID: 33308263
[TBL] [Abstract][Full Text] [Related]
16. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome.
Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A;
Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170
[TBL] [Abstract][Full Text] [Related]
17. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
Trials; 2015 Aug; 16():373. PubMed ID: 26297658
[TBL] [Abstract][Full Text] [Related]
18. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427
[TBL] [Abstract][Full Text] [Related]
19. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Trials; 2014 Dec; 15():511. PubMed ID: 25540987
[TBL] [Abstract][Full Text] [Related]
20. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
Trials; 2023 May; 24(1):367. PubMed ID: 37259112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
